MiR ‐20a‐5p Inhibits Bladder Cancer Proliferation and Migration by Targeting KPNA2
Journal of Cellular and Molecular Medicine · 2025-08 · 29 (16)
DOI: 10.1111/jcmm.70785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 19.08.2025. Verfasst von Shuai Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: MicroRNAs, alpha Karyopherins, Cell Movement, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Technology and Innovation Commission of Shenzhen Municipality, Sanming Project of Medicine in Shenzen, Sanming Project of Medicine in Shenzen Municipality.
Abstract (Originalsprache)
Bladder cancer (BC) is one of the 10 most common cancers in the world, and its recurrence and metastasis are the main causes of death in BC patients. Exploring the molecular mechanisms of BC pathogenesis and searching for new prognostic markers and therapeutic targets are important for improving patient prognosis. KPNA2 was found to be a potential oncogene in different malignant tumours, as demonstrated in our previous study. To better understand the mechanisms associated with BC development, we investigated the inhibitory effect of miR‐20a‐5p on the oncogene KPNA2. RNA‐seq data from BC patients were downloaded through the TCGA database for bioinformatics analysis, including gene expression, co‐expression analysis, GSEA, nomogram modelling, functional enrichment analysis, WGCNA, GO and KEGG to assess the potential biological functions of miR‐20a‐5p in BC. Subsequently, we further verified the expression of miR‐20a‐5p in BC cells by RT‐qPCR, and in vitro experiments were performed to investigate the effects of this gene on BC cell proliferation and migration. MiR‐20a‐5p was downregulated in BC tissues and cells. Kaplan–Meier analysis revealed that the higher the expression of miR‐20a‐5p in patients, the higher the survival rate of BC patients. MiR‐20a‐5p overexpression inhibited the proliferation and migration of BC cells. In addition, miR‐20a‐5p can directly bind to nuclear transporter protein α2 (KPNA2) in cells, targeting and regulating the expression of KPNA2. These findings indicate that miR‐20a‐5p targeting KPNA2 adversely affects the proliferation and migration of BC cells, suggesting that miR‐20a‐5p may be an attractive target in BC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
- Shenzhen University Health Science Center, Shenzhen, China.
- Shantou University Medical College, Shantou, China.
- Department of Urology, Peking University Shenzhen Hospital, Institute of Urology, Shenzhen PKU-HKUST Medical Center, Shenzhen, China.
- Central Laboratory, Shenzhen Qianhai Taikang Hospital, Shenzhen, China.
ORCID-Profile: Bentao Shi
Förderung
- Science Technology and Innovation Commission of Shenzhen Municipality
- Sanming Project of Medicine in Shenzen
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Ye, S., Liufu, C., Yin, C., Zhu, T., He, J., Tian, Y., Wang, Y., & Shi, B. (2025). MiR ‐20a‐5p Inhibits Bladder Cancer Proliferation and Migration by Targeting KPNA2. Journal of Cellular and Molecular Medicine, 29(16). https://doi.org/10.1111/jcmm.70785
Vancouver
Ye S, Liufu C, Yin C, Zhu T, He J, Tian Y, et al. MiR ‐20a‐5p Inhibits Bladder Cancer Proliferation and Migration by Targeting KPNA2. Journal of Cellular and Molecular Medicine. 2025;29(16). doi:10.1111/jcmm.70785
BibTeX
@article{Ye2025,
author = {Ye, Shuai and Liufu, Cen and Yin, Cong and Zhu, Tao and He, Jinqing and Tian, Yuanyuan and Wang, Yan and Shi, Bentao},
title = {MiR ‐20a‐5p Inhibits Bladder Cancer Proliferation and Migration by Targeting KPNA2},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {16},
doi = {10.1111/jcmm.70785}
}
EUVIMED